Accessibility Menu
Ventripoint Diagnostics logo

Ventripoint Diagnostics(TSXV) VPT

Current PriceCA$0.11
Market CapCA$22.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-97%
5 Year-69%
1 Year-25%
1 Month-5%
Ventripoint Diagnostics last closing stock price
MetricPriceDate
Last closeCAD 0.112026-07-23
Ventripoint Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.55%CAD 0.112026-07-16
1 month-4.55%CAD 0.112026-06-23
3 month+0%CAD 0.112026-04-24
Year to date-25%CAD 0.142025-12-31
1 year-25%CAD 0.142025-07-23
3 year-65%CAD 0.302023-07-24
5 year-68.66%CAD 0.342021-07-23
Since inception-97.13%CAD 4.002007-09-21

Ventripoint Diagnostics Financials at a Glance

Market Cap

CA$22.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$179.93K

Net Income (TTM)

-CA$3.20M

EPS (TTM)

-CA$0.02

P/E Ratio

-5.93

Dividend

CA$0.00

Beta (Volatility)

0.63 (Low)

Price

CA$0.11

Volume

37,101

Open

CA$0.11

Previous Close

CA$0.11

Daily Range

CA$0.11 - CA$0.11

52-Week Range

CA$0.08 - CA$0.19

Estimated Earnings Date

Jul 23, 2026

VPT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

VentriPoint Diagnostics Ltd. is a medical technology company dedicated to developing and commercializing innovative diagnostic tools for cardiovascular disease. The company’s flagship product, the Ventripoint Medical System (VMS), offers advanced imaging capabilities to generate precise 3D models of the heart's chambers.

Products and Services
  • Ventripoint Medical System (VMS) for cardiac imaging
  • VMS+ software for processing echocardiogram and MRI data
  • Specialized applications targeting various cardiac conditions
Growth Outlook
  • Expansion into specialized applications for congenital heart disease and pulmonary hypertension
  • Increasing demand for advanced cardiac imaging solutions globally
  • Potential partnerships with healthcare providers to enhance market reach
Financial Highlights
  • Recent quarterly revenue of CAD 4,304, indicating ongoing operational challenges
  • Trailing twelve months (TTM) net income margin of -17.79%, reflecting investment in R&D
  • Cash and cash equivalents of CAD 55,389, supporting ongoing operations
VentriPoint Diagnostics Ltd. operates in a niche market with significant growth potential, particularly in the realm of cardiac diagnostics. The VMS technology is designed to improve the accuracy and efficiency of heart assessments, which is crucial for timely and effective treatment of cardiovascular diseases. Despite recent financial challenges, the company is focused on expanding its product offerings and enhancing its market presence. The ongoing investment in research and development aims to position VentriPoint as a leader in the medical imaging sector, catering to the increasing global demand for advanced diagnostic tools.
AI Generated • Jul 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Hugh MacNaught

Website

www.ventripoint.com

Headquarters

Toronto, ON M6P 1T4, CA

VPT Financials

Key Financial Metrics (TTM)

Gross Margin

82.94%

Operating Margin

-1889.37%

Net Income Margin

-1778.62%

Return on Equity

78.25%

Return on Capital

N/A

Return on Assets

-677.90%

Earnings Yield

-16.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$22.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

192.58M

Volume

37.10K

Avg. Volume

141.41K

Financials (TTM)

Gross Profit

CA$149.22K

Operating Income

-CA$3.40M

EBITDA

-CA$2.67M

Operating Cash Flow

-CA$1.55M

Capital Expenditure

-CA$5.00

Free Cash Flow

-CA$1.55M

Cash & ST Invst.

CA$55.39K

Total Debt

CA$2.60M

Ventripoint Diagnostics Performance Analysis

Ventripoint Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 68,167N/A
20232023-12-31CAD 49,183-27.8%
20242024-12-31CAD 95,17293.5%
20252025-12-31CAD 179,92889.1%
Ventripoint Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31N/A
Q22025-06-30-100.0%
Q32025-09-30N/A
Q42025-12-31-95.9%
Ventripoint Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.039.5%
20232023-12-31CAD -0.03-0.3%
20242024-12-31CAD -0.030.0%
20252025-12-31CAD -0.02-37.6%
Ventripoint Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3110.6%
Q22025-06-30-33.9%
Q32025-09-3043.0%
Q42025-12-3173.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$4.30K

N/A

Gross Profit

-CA$11.13K

+27.9%

Gross Margin

-2.59%

N/A

Market Cap

CA$22.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$2.21M

N/A

Employees

10

N/A

Net Income

-CA$199.75K

+81.1%

EBITDA

-CA$62.74K

+94.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$55.39K

-8.5%

Total Debt

CA$2.60M

+59.1%

Accounts Receivable

CA$132.99K

-47.1%

Inventory

CA$0.00

N/A

Long Term Debt

CA$115.37K

-45.7%

Short Term Debt

CA$2.50M

+75.5%

Return on Assets

-6.78%

N/A

Return on Invested Capital

84.96%

N/A

Free Cash Flow

-CA$599.37K

+16.8%

Operating Cash Flow

-CA$599.37K

+16.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASG.VAurora Spine Corporation
CA$0.21+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
NUNu Holdings
$14.19-0.02%
INTCIntel
$100.23-0.02%

Questions About VPT

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at CA$0.11 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between CA$0.08 and CA$0.19.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of CA$2.60M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported CA$55.39K in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services